ZepBound® & Weight Loss Injections in Los Angeles, CA
JASI Skin + Wellness Med Spa offers physician-supervised ZepBound® (tirzepatide) weight loss injections in Los Angeles, with a medically guided program designed to address the root causes of weight gain, not just the symptoms. If you’ve tried dieting and exercise without lasting results, GLP-1 and GIP receptor agonist therapy may be the clinical solution your body actually needs. Your provider evaluates your full medical profile, confirms eligibility, and builds a treatment plan around you. Real oversight. Real results.
Ready to find out if you qualify? Call us at (424) 478-0522 to schedule your screening today.
Contact UsPhysician-Supervised Weight Loss Injections at JASI Skin + Wellness Med Spa
Our practice delivers ZepBound® (tirzepatide) as part of a medically overseen program, not a mail-order kit or a self-administered protocol. ZepBound® is a dual GIP and GLP-1 receptor agonist, which sets it apart from single-pathway medications you may have heard of, such as the semaglutide products Ozempic and Wegovy. Treatment is available at our Los Angeles location at 811 W St Johns Ave, with patients traveling from neighborhoods including West Hollywood, Koreatown, Santa Monica, and the South Bay.
This is a real medical program. Your specialist reviews your health history, determines candidacy, and monitors your progress at every stage. In the SURMOUNT-1 trial, participants at the highest dose lost an average of roughly 20.9% of their body weight, and outcomes improve further when a program is properly supervised. In a city saturated with telehealth-only providers that mail medications after a brief online form, that level of in-person oversight is exactly what separates our approach.
Many patients also pair their weight loss program with facial and skin treatments or microneedling treatments as their body composition changes. We hold a 5.0 rating across 320 Google reviews. Call us at (424) 478-0522 to find out if you qualify.
How Do ZepBound® Weight Loss Injections Work?
Tirzepatide, the active ingredient in ZepBound®, activates two metabolic pathways at once. It mimics GLP-1 (glucagon-like peptide-1), a hormone your gut naturally releases after eating that binds to receptors in the hypothalamus to signal satiety. It also activates GIP (glucose-dependent insulinotropic polypeptide), a second incretin pathway that supports insulin sensitivity. Together these actions slow gastric emptying, so food stays in your stomach longer and caloric intake drops without requiring constant willpower.
Dual GIP and GLP-1 Receptor Agonism: The Science Behind Appetite Suppression
You may be more familiar with semaglutide, the medication sold as Ozempic and Wegovy, which works through the GLP-1 pathway alone. ZepBound® adds the second GIP mechanism on top of that. This is not a stimulant or a crash diet in a syringe. It is a pharmacological shift in metabolic signaling that addresses the hormonal drivers of overeating directly.
Where semaglutide activates one metabolic pathway, tirzepatide activates two simultaneously, amplifying both appetite suppression and insulin sensitivity. That dual-agonist action is the reason our clinical team has built our medically supervised program around ZepBound® rather than a single-pathway medication.
Ready to find out if ZepBound® is right for your goals? Call (424) 478-0522 to schedule your evaluation.
Clinical Outcomes from Published Trial Data
In the SURMOUNT-1 trial, participants taking the highest dose of tirzepatide lost an average of about 20.9% of their body weight. For a 200-pound person, that translates to roughly 42 pounds of documented, measurable loss. Those figures come from published clinical research, not marketing claims.
For context, single-pathway semaglutide produced an average loss of 14.9% over 68 weeks in the STEP 1 trial. Published outcomes like these were achieved under physician-supervised protocols, which is exactly the standard our team holds here. Many people exploring weight loss injections in Los Angeles encounter mail-order programs with no clinical oversight, and that gap in supervision is one of the biggest differences in real-world results.
ZepBound® vs. Semaglutide: Understanding the Difference
Semaglutide works through a single GLP-1 pathway, delivered as a weekly subcutaneous injection under the brand names Ozempic and Wegovy, with average body weight reduction of roughly 15% in the STEP trials. Tirzepatide adds a second mechanism, activating both GLP-1 and GIP receptors at the same time. That dual-pathway action produced average weight loss of 20 to 22% in the SURMOUNT trials.
Individual response still varies. Greater average efficacy does not automatically mean a medication is the right fit for every patient, which is why tolerability, side-effect profile, and cost all factor into the plan your provider builds with you. For a full picture, explore our weight loss programs in Los Angeles.
Our ZepBound® Program: Candidacy, Process, and Pricing
Before any prescription is written, your specialist conducts a full health history review, assesses your current medications for interactions, and has a direct goal-setting conversation with you. Most patients self-administer a small subcutaneous ZepBound® injection at home once weekly, and we walk you through proper injection sites and dosing before you leave.
Who Is a Candidate for ZepBound®?
Eligibility: You may qualify if you have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as type 2 diabetes, hypertension, or dyslipidemia. Contraindications include a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, and active pancreatitis.
Our Intake Process: Your provider evaluates your full medical profile at consultation. There are no shortcuts here. If a contraindication is present, we will not prescribe the medication, and we will discuss alternatives that are appropriate for your situation. Call us at (424) 478-0522 to schedule your evaluation.
Consultation, Injections, and Follow-Up
First Visit: Your provider reviews your medical history, current medications, and goals, then discusses lab work where appropriate. Most patients self-administer a small subcutaneous ZepBound® injection at home once weekly, similar in technique to an insulin pen.
Ongoing Care: During the titration phase we monitor you closely, adjusting your dose to balance effectiveness against side effects like nausea, then shift to longer intervals once you reach a stable maintenance dose. Follow-up appointments are typically every four weeks during active titration, shifting to every six to eight weeks at maintenance.
Pricing and Membership Tiers
Monthly Membership: Our program is a transparent monthly membership. Every tier includes weekly ZepBound® injections and personalized support, structured for long-term results.
- Lite (2.5 to 5 mg): $600 per month
- Core (7.5 to 10 mg): $850 per month
- Max (12.5 to 15 mg): $1,050 per month
Insurance: Most GLP-1 based programs are not covered by standard insurance, though some plans may reimburse a portion when a physician documents a qualifying metabolic diagnosis. Contact us to review the tiers and confirm the right starting point during your consultation.
Weight Loss Injections by Patient Profile
The right approach depends on your health history, metabolic goals, and how your body responds to treatment. There is no single protocol. Your provider evaluates your full picture before any prescription is written.
When Diet and Exercise Have Not Moved the Scale
If you have maintained a caloric deficit, exercised consistently, and still cannot lose weight, the problem is not willpower. It is physiology. Metabolic adaptation reduces your resting energy expenditure over time. Insulin resistance blunts your body's ability to use stored fat efficiently. And hormonal dysregulation keeps hunger signals elevated even when you are eating less.
ZepBound® addresses these hormonal factors directly. Its dual GIP and GLP-1 action slows gastric emptying, reduces appetite signaling at the brain level, and improves insulin sensitivity. This is not a shortcut. It is a targeted intervention for a physiological problem that lifestyle changes alone cannot fully correct.
Patients with Metabolic Conditions
Tirzepatide, the active ingredient in ZepBound®, is also marketed as Mounjaro for glycemic control in type 2 diabetes, which speaks to its established metabolic profile. If you have type 2 diabetes, prediabetes, or hypertension, a supervised ZepBound® program can address both your metabolic markers and your body composition at the same time.
Because ZepBound® works through both the GLP-1 and GIP pathways, it carries dual metabolic applications that are particularly relevant for patients managing blood sugar alongside weight. Physician supervision is not optional for this patient group. Appropriate lab monitoring and medication coordination are required, and our clinical team structures every program with that level of oversight built in.
Combining Weight Loss with Aesthetic Goals
Los Angeles has a uniquely image-conscious wellness culture, and patients here frequently pursue weight loss and aesthetic refinement at the same time. Significant weight loss, particularly rapid loss, can reduce facial volume in ways that read as premature aging. Your provider can discuss dermal fillers or cheek filler to restore midface volume and maintain facial balance as your body composition changes.
Rapid weight loss can also trigger telogen effluvium, a temporary but noticeable form of hair shedding caused by physiological stress. If you notice increased hair loss during your program, our hair restoration services are available to address it early. Call us at (424) 478-0522 to discuss your full picture before starting.
Ready to find out whether ZepBound® is the right fit for your goals? Call us at (424) 478-0522 or book a consultation online. Our Los Angeles team will review your health history, answer your questions, and build a physician-supervised plan before any prescription is written. No pressure, no guesswork. Just a clear clinical path forward.
Explore Our Full Range of Services
Weight loss injections are one part of what we do. Browse the complete menu of treatments available across all JASI Skin + Wellness locations.
Aerolase
Aerolase® Laser TherapyLaser Hair Removal
Laser Hair RemovalPRF & EZ Gel
PRF & PRP TreatmentsMicroneedling
MicroneedlingHair Health
Hair RestorationAreas We Serve
JASI Clinic, Los Angeles
11695 National Blvd.
Los Angeles, CA 90064
JASI Clinic, Torrance
21250 Hawthorne Blvd, Suite 170 - Studio 107,
Torrance, CA 90503
JASI Clinic, Las Vegas
8861 W Sahara Ave, Suite 190
Las Vegas, NV 89117
See What Our Customers Have To Say
Ready to Get Started with JASI Skin + Wellness Med Spa?
Call (424) 478-0522 to speak with our team directly. We’re ready to answer your questions, walk you through your options, and help you find the right solution for your needs. Whether you’re just starting to plan or ready to move forward, we’ll make the process simple and stress-free.
Reach out today and let’s talk about how we can help.
Frequently Asked Questions
Most patients at JASI Skin + Wellness Med Spa notice appetite changes within the first one to two weeks of starting ZepBound®. Measurable weight loss typically becomes visible between weeks four and eight, depending on starting dose and individual metabolism. Full clinical results are generally evaluated at the three to six month mark, when dosage titration is complete.
ZepBound® manages appetite and metabolism while you are taking it, so some weight regain is possible after stopping without a transition plan in place. Our clinic incorporates an off-ramp strategy into each patient’s protocol, including nutritional guidance to help maintain results. Patients who have reached their goal weight are monitored closely during the discontinuation phase to reduce rebound risk.
Compounded versions of tirzepatide carry variable quality standards because they are not FDA-approved finished drug products, which is why sourcing matters significantly. Our practice uses only pharmacy-grade, physician-prescribed brand-name ZepBound® with documented purity and potency. Patients are advised to ask any provider about the source and testing standards of any compounded medication before starting treatment.
Prior bariatric surgery does not automatically disqualify a patient from ZepBound® therapy, but it does require a more detailed intake evaluation. Our physicians review surgical history, current absorption status, and any nutritional deficiencies before recommending a protocol. In some post-bariatric cases, lower starting doses and closer follow-up intervals are recommended to avoid compounding gastrointestinal side effects.
Our program is a transparent monthly membership priced by dose tier: Lite (2.5 to 5 mg) at $600 per month, Core (7.5 to 10 mg) at $850 per month, and Max (12.5 to 15 mg) at $1,050 per month. Every tier includes weekly ZepBound® injections and personalized support. Most programs are not covered by standard insurance, though some plans may reimburse a portion when a physician documents a qualifying metabolic diagnosis.
We typically schedule follow-up appointments every four weeks during the active titration phase of treatment. These visits allow the physician team to assess tolerance, adjust dosing, and track biometric progress including weight, body composition, and relevant lab values. Once a patient reaches a stable maintenance dose, appointment frequency may shift to every six to eight weeks depending on individual progress.
Many patients do combine weight loss injection consultations with aesthetic treatments such as body contouring or skin tightening on the same visit. However, certain procedures may require the physician to review your current medication status and recent weight changes before proceeding. The team will advise on timing based on which treatments you are receiving and how your body is responding to the injection protocol.